NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Framework (Products)
- Duration
- 3 year
- Value
- £424M
- Sector
- HEALTH
- Published
- 14 May 2024
- Delivery
- 01 Jun 2024 to 31 May 2027
- Deadline
- 23 Nov 2023 13:00
Concepts
Location
1 buyer
- NHS England Runcorn
63 suppliers
- Milpharm South Ruislip
- Kent Pharma Ashford
- Fresenius Kabi Runcorn
- Selective Supplies London
- Novumgen Hemel Hempstead
- Medreich Feltham
- Martindale Pharma High Wycombe
- Bowmed Ibisqus Chirk
- Wockhardt Wrexham
- Zentiva Pharma Guildford
- Ipca Laboratories Uxbridge
- Roma Pharmaceuticals Burton on Trent
- Perennial Pharma Hatfield
- Consilient Health Richmond
- Pfizer Tadworth
- Rosemont Pharmaceuticals Welwyn Garden City
- Glaxosmithkline Brentford
- Seacross Pharmaceuticals Stanmore
- Aventis Pharma Reading
- B Braun Medical Sheffield
- Macleods Pharma Billingham
- Sandoz Camberley
- Flynn Pharma Stevenage
- Drreddys Laboratories Cambridge
- Torbay Pharmaceuticals Paington
- Lucane Pharma Ankeveen
- Glenmark Pharmaceuticals Europe Watford
- Esteve Pharmaceuticals Maidenhead
- Healthcare Pharma Haslemere
- Sun Pharma Uxbridge
- Rovi Biotech Croydon
- Pari West Byfleet
- CST Pharma Walsall
- Teva Castleford
- Gerot Lannach Ely
- Hameln Pharma Gloucester
- Alissa Healthcare Research Fareham
- Mylan Hatfield
- Flexipharm Austrading Bourne End
- Day Lewis Medical Croydon
- Morningside Pharmaeuticals Loughborough
- Ennogen Healthcare Dartford
- Venture Healthcare Surbiton
- Medac Pharma Stirling
- Mercury Pharmaceuticals London
- Agb Pharma Lund
- Thornton & Ross Huddersfield
- Sobi Swedish Orphan Biovitrum Great Abingdon
- Organon Pharmaceuticals London
- Piramal Critical Care West Drayton
- Janssen Cilag High Wycombe
- Aguettant Bristol
- Amarox Harrow
- Colonis Pharma Weybridge
- Gennisium Pharma Vitrolles
- Neuraxpharm Reading
- Desitin Pharma Milton Keynes
- Otsuka Pharmaceuticals Windsor
- Tillotts Pharma Wellingore
- Abbvie Maidenhead
- GH Pharma Salford
- Aspire Pharma Petersfield
- Panpharma Southport
Description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Award Detail
1 | Milpharm (South Ruislip)
|
2 | Kent Pharma (Ashford)
|
3 | Fresenius Kabi (Runcorn)
|
4 | Selective Supplies (London)
|
5 | Novumgen (Hemel Hempstead)
|
6 | Medreich (Feltham)
|
7 | Martindale Pharma (High Wycombe)
|
8 | Bowmed Ibisqus (Chirk)
|
9 | Wockhardt (Wrexham)
|
10 | Zentiva Pharma (Guildford)
|
11 | Ipca Laboratories (Uxbridge)
|
12 | Roma Pharmaceuticals (Burton on Trent)
|
13 | Perennial Pharma (Hatfield)
|
14 | Consilient Health (Richmond)
|
15 | Pfizer (Tadworth)
|
16 | Rosemont Pharmaceuticals (Welwyn Garden City)
|
17 | Glaxosmithkline (Brentford)
|
18 | Seacross Pharmaceuticals (Stanmore)
|
19 | Aventis Pharma (Reading)
|
20 | B Braun Medical (Sheffield)
|
21 | Macleods Pharma (Billingham)
|
22 | Sandoz (Camberley)
|
23 | Flynn Pharma (Stevenage)
|
24 | Drreddys Laboratories (Cambridge)
|
25 | Torbay Pharmaceuticals (Paington)
|
26 | Lucane Pharma (Ankeveen)
|
27 | Glenmark Pharmaceuticals Europe (Watford)
|
28 | Esteve Pharmaceuticals (Maidenhead)
|
29 | Healthcare Pharma (Haslemere)
|
30 | Sun Pharma (Uxbridge)
|
31 | Rovi Biotech (Croydon)
|
32 | Pari (West Byfleet)
|
33 | CST Pharma (Walsall)
|
34 | Teva (Castleford)
|
35 | Gerot Lannach (Ely)
|
36 | Hameln Pharma (Gloucester)
|
37 | Alissa Healthcare Research (Fareham)
|
38 | Mylan (Hatfield)
|
39 | Flexipharm Austrading (Bourne End)
|
40 | Day Lewis Medical (Croydon)
|
41 | Morningside Pharmaeuticals (Loughborough)
|
42 | Ennogen Healthcare (Dartford)
|
43 | Venture Healthcare (Surbiton)
|
44 | Medac Pharma (Stirling)
|
45 | Mercury Pharmaceuticals (London)
|
46 | Agb Pharma (Lund)
|
47 | Thornton & Ross (Huddersfield)
|
48 | Sobi Swedish Orphan Biovitrum (Great Abingdon)
|
49 | Organon Pharmaceuticals (London)
|
50 | Piramal Critical Care (West Drayton)
|
51 | Janssen Cilag (High Wycombe)
|
52 | Aguettant (Bristol)
|
53 | Amarox (Harrow)
|
54 | Colonis Pharma (Weybridge)
|
55 | Gennisium Pharma (Vitrolles)
|
56 | Neuraxpharm (Reading)
|
57 | Desitin Pharma (Milton Keynes)
|
58 | Otsuka Pharmaceuticals (Windsor)
|
59 | Tillotts Pharma (Wellingore)
|
60 | Abbvie (Maidenhead)
|
61 | GH Pharma (Salford)
|
62 | Aspire Pharma (Petersfield)
|
63 | Panpharma (Southport)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract is suitable for SMEs.
Other Information
Transparency Award Schedule - Wave 14c Lot 2 5672_02 Transparency Award Schedule - Wave 14c Lot 2 5672_02.pdf Transparency Award Schedule - Wave 14c Lot 1 5672_01 Transparency Award Schedule - Wave 14c Lot 1 5672_01.pdf Wave 14c Parties Appointed & SME Status Wave 14c Parties Appointed & SME Status.xlsx Framework Agreement and Terms and Conditions - Wave 14c Framework Agreement and Terms and Conditions - Wave 14c.pdf Transparency Award Schedule - Wave 14c Lot 3 5672_03 Transparency Award Schedule - Wave 14c Lot 3 5672_03.pdf
Reference
- CF-2353600D0O000000rwimUAA
- CF a61d79ec-c723-4171-8941-70f546470f90